Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
50.00
0.00 (0.00%)
Oct 27, 2026, 9:14 AM JST

Chordia Therapeutics Balance Sheet

Millions JPY. Fiscal year is Sep - Aug.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Cash & Equivalents
2,0522,5494,3304,799
Cash & Short-Term Investments
2,0522,5494,3304,799
Cash Growth
-19.49%-41.13%-9.78%-
Prepaid Expenses
17.4324.938.1652.06
Other Current Assets
32.7295.18237.6440.52
Total Current Assets
2,1022,6694,6054,892
Property, Plant & Equipment
--2.754.43
Other Intangible Assets
--0.622.5
Other Long-Term Assets
1212.3223.5910.59
Total Assets
2,1142,6814,6324,909

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Accounts Payable
93.48120.01382.43248.43
Accrued Expenses
129.332.325.6
Current Income Taxes Payable
9.1190.554.292.42
Other Current Liabilities
85.244.532.06131.79
Total Current Liabilities
188.84244.34471.07408.24
Other Long-Term Liabilities
000-
Total Liabilities
188.84244.34471.07408.24

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Common Stock
1,346876.27845.2790
Additional Paid-In Capital
2,0289,0669,0358,280
Retained Earnings
-1,455-7,508-5,722-3,895
Comprehensive Income & Other
7.122.522.9425.93
Shareholders' Equity
1,9262,4374,1614,501
Total Liabilities & Equity
2,1142,6814,6324,909

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Net Cash (Debt)
2,0522,5494,3304,799
Net Cash Growth
-19.49%-41.13%-9.78%-
Net Cash Per Share
27.8437.1573.7285.02
Filing Date Shares Outstanding
77.2668.9967.6856.44
Total Common Shares Outstanding
77.2668.9967.6856.44
Working Capital
1,9142,4254,1344,483
Book Value Per Share
24.9235.3261.4979.74
Tangible Book Value
1,9262,4374,1614,498
Tangible Book Value Per Share
24.9235.3261.4879.70
Machinery
10.4810.4811.2110.68